| # | Title | Journal | Year | Citations |
|---|
| 1 | Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease | Gastroenterology | 2015 | 725 |
| 2 | Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2013 | 340 |
| 3 | No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial | Gastroenterology | 2014 | 260 |
| 4 | Excess mortality on the liver transplant waiting list: Unintended policy consequences and model for End‐Stage Liver Disease (MELD) inflation | Hepatology | 2015 | 159 |
| 5 | Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes | Hepatology | 2012 | 150 |
| 6 | Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease | Liver International | 2013 | 123 |
| 7 | Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies | Hepatology | 2018 | 100 |
| 8 | Nonalcoholic fatty liver disease: another leap forward | Nature Reviews Gastroenterology and Hepatology | 2021 | 89 |
| 9 | Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver | European Journal of Nutrition | 2010 | 83 |
| 10 | Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH | Hepatology | 2020 | 79 |
| 11 | Variation in Aptitude of Trainees in Endoscopic Ultrasonography, Based on Cumulative Sum Analysis | Clinical Gastroenterology and Hepatology | 2015 | 71 |
| 12 | Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum | Journal of Hepatology | 2020 | 69 |
| 13 | Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis | Journal of Hepatology | 2019 | 60 |
| 14 | A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study | Contemporary Clinical Trials | 2020 | 53 |
| 15 | Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction | JACC Basic To Translational Science | 2021 | 41 |
| 16 | Systematic transcriptome analysis reveals elevated expression of alcohol‐metabolizing genes in NAFLD livers | Journal of Pathology | 2016 | 40 |
| 17 | Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial | The Lancet Gastroenterology and Hepatology | 2022 | 40 |
| 18 | Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men | Clinical Gastroenterology and Hepatology | 2021 | 37 |
| 19 | Colorectal Cancer Testing in the National Veterans Health Administration | Digestive Diseases and Sciences | 2012 | 27 |
| 20 | Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox | Liver Transplantation | 2020 | 26 |
| 21 | Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD | Clinical Gastroenterology and Hepatology | 2021 | 25 |
| 22 | Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis | Nature Communications | 2022 | 24 |
| 23 | Procedural Competency of Gastroenterology Trainees: From Apprenticeship to Milestones | Gastroenterology | 2013 | 19 |
| 24 | Diabetes and Kidney Disease in American Indians: Potential Role of Sugar-Sweetened Beverages | Mayo Clinic Proceedings | 2015 | 19 |
| 25 | A pre-marketing ALT signal predicts post-marketing liver safety | Regulatory Toxicology and Pharmacology | 2012 | 14 |
| 26 | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis | Translational Gastroenterology and Hepatology | 2021 | 13 |
| 27 | Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy | American Journal of Hematology | 2021 | 13 |
| 28 | Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study | Hepatology Communications | 2022 | 12 |
| 29 | Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases | Gastroenterology | 2021 | 11 |
| 30 | The role of bariatric surgery in the management of nonalcoholic steatohepatitis | Current Opinion in Gastroenterology | 2021 | 11 |
| 31 | Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation | Digestive Diseases and Sciences | 2018 | 10 |
| 32 | American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease | Hepatology Communications | 2023 | 9 |
| 33 | Core curriculum for EUS | Gastrointestinal Endoscopy | 2020 | 7 |
| 34 | Core curriculum for endoscopic mucosal resection | Gastrointestinal Endoscopy | 2021 | 7 |
| 35 | Nonalcoholic Fatty Liver Disease | North Carolina Medical Journal | 2016 | 6 |
| 36 | Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH | Clinical Liver Disease | 2021 | 4 |
| 37 | Reply: Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? | Hepatology | 2010 | 3 |
| 38 | Core curriculum for endoscopic ablative techniques | Gastrointestinal Endoscopy | 2021 | 3 |
| 39 | Burden of early hospitalization after simultaneous liver–kidney transplantation: Results from the US Multicenter SLKT Consortium | Liver Transplantation | 2022 | 3 |
| 40 | Core curriculum for endoluminal stent placement | Gastrointestinal Endoscopy | 2020 | 2 |
| 41 | Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis | Hepatology | 2018 | 1 |
| 42 | Centers of Excellence in Hepatology: Making the Case to Insurers, Large Employers, and Patients | Clinical Gastroenterology and Hepatology | 2021 | 1 |
| 43 | Being Well Informed Is Critical to Informed Consent for Living Liver Donors | Transplantation | 2021 | 1 |
| 44 | Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis | Transplantation | 2018 | 1 |
| 45 | Successful management of persistent post–peroral endoscopic myotomy esophageal leak with fibrin glue | Gastrointestinal Endoscopy | 2020 | 1 |
| 46 | Chronic Abdominal Pain in a Liver Transplant Recipient | American Journal of Transplantation | 2013 | 0 |
| 47 | Reply | Hepatology | 2015 | 0 |
| 48 | Reply to Kim et al. | American Journal of Gastroenterology | 2017 | 0 |
